StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 16.6 % Shares of BTX stock opened at $1.51 on Thursday. The firm has a market capitalization of $88.83 million, a price-to-earnings ratio of […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Tuesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 1.6 % Shares of NYSE:BTX opened at $0.90 on Tuesday. The firm’s 50 day moving average is $1.59 and its two-hundred day moving average […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 7.3 % Brooklyn ImmunoTherapeutics stock opened at $1.01 on Monday. The firm has a market cap of $59.41 million, a […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of NYSE:BTX opened at $1.15 on Friday. Brooklyn ImmunoTherapeutics has a one year low of $0.17 and a one year high of $10.10. […]
StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Friday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance NYSE BTX opened at $1.37 on Friday. The firm has a market capitalization of $80.59 million, a P/E ratio of -1.81 and a […]